-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Acrivon Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2021 to Q2 2024.
- Acrivon Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.57M, a 32.8% increase year-over-year.
- Acrivon Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $13.2M, a 82.1% increase year-over-year.
- Acrivon Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $11.6M, a 432% increase from 2022.
- Acrivon Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.19M, a 340% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)